Clinical Trial: Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: A Randomized, Double-Blind, Placebo-controlled, Efficacy, Safety, and Tolerability Study of Bifeprunox in the Treatment of Elderly Subjects With Psychosis and Behavioral Disturba
Brief Summary: This is a 10-week study with bifeprunox and placebo in elderly subjects with psychosis and behavioral disturbances associated with dementia of the alzheimer's type.
Detailed Summary:
Sponsor: Solvay Pharmaceuticals
Current Primary Outcome: Brief Psychiatric Rating Scale (BPRS) Total Score [ Time Frame: 10 weeks ]
Original Primary Outcome:
Current Secondary Outcome: Adverse events [ Time Frame: 10 weeks ]
Original Secondary Outcome:
Information By: Solvay Pharmaceuticals
Dates:
Date Received: September 8, 2005
Date Started: December 2005
Date Completion:
Last Updated: January 29, 2015
Last Verified: June 2009